Midatech Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Midatech Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 21% to $699,000. Profit margin reached -1095%. Total operating expenses were $4,520,000.

Profit Margin

Midatech Pharma plc (LSE:MTPH.L): Profit margin
2013 147K -4.08M -2778.23%
2014 157K -7.38M -4701.91%
2015 1.37M -10.09M -734.47%
2016 6.92M -20.16M -291.23%
2017 7.59M -16.06M -211.42%
2018 1.93M -10.36M -534.98%
2019 674K -9.13M -1355.79%
2020 343K -22.18M -6469.1%
2021 578K -5.46M -944.64%
2022 699K -7.65M -1095.28%

MTPH.L Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
699K578K343K674K1.93M7.59M6.92M1.37M157K147K
Cost of revenue
5.11M4.65M6.06M7.84M8.55M11.11M667K70K3.63M1.92M
Gross profit
-4.41M-4.07M-5.72M-7.16M-6.61M-3.51M6.25M1.30M-3.48M-1.77M
Operating exp.
Research and development
00008.55M10.18M6.68M5.92M3.63M2.84M
Selling and marketing
006K323K09.41M9.52M374K00
Total operating expenses
4.52M2.92M4.94M4.14M5.19M12.56M25.42M14.22M4.40M2.72M
Operating income
-8.93M-6.99M-23.04M-11.31M-11.81M-17.57M-30.58M-12.91M-7.88M-4.49M
Other income (expenses), net
444K892K-430K395K-585K249K1.17M1.68M-153K-137K
Income before tax
-8.48M-6.10M-23.47M-10.92M-12.4M-17.32M-29.32M-11.23M-8.04M-4.88M
Income tax expense
-832K-646K-1.28M-1.78M-2.03M-1.26M-9.16M-1.13M-658K-799K
Net income
-7.65M-5.46M-22.18M-9.13M-10.36M-16.06M-20.16M-10.09M-7.38M-4.08M
Earnings per share
Basic EPS
0-1.36-10.36-9.06-66.85-123.37-220.28-141.88-322.33-57.91
Diluted EPS
0-1.36-10.36-9.06-66.85-123.37-220.28-141.88-322.33-57.91
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source